Ethanol-Induced Oxidative Stress Modifies Inflammation and Angiogenesis Biomarkers in Retinal Pigment Epithelial Cells (ARPE-19): Role of CYP2E1 and its Inhibition by Antioxidants.
CYP2E1
degeneration
homeostasis
oxidative stress
retinal pigment epithelium
Journal
Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981
Informations de publication
Date de publication:
21 Aug 2020
21 Aug 2020
Historique:
received:
14
07
2020
revised:
15
08
2020
accepted:
19
08
2020
entrez:
23
8
2020
pubmed:
23
8
2020
medline:
23
8
2020
Statut:
epublish
Résumé
The retinal pigment epithelium (RPE) plays a key role in retinal health, being essential for the protection against reactive oxygen species (ROS). Nevertheless, excessive oxidative stress can induce RPE dysfunction, promoting visual loss. Our aim is to clarify the possible implication of CYP2E1 in ethanol (EtOH)-induced oxidative stress in RPE alterations. Despite the increase in the levels of ROS, measured by fluorescence probes, the RPE cells exposed to the lowest EtOH concentrations were able to maintain cell survival, measured by the Cell Proliferation Kit II (XTT). However, EtOH-induced oxidative stress modified inflammation and angiogenesis biomarkers, analyzed by proteome array, ELISA, qPCR and Western blot. The highest EtOH concentration used stimulated a large increase in ROS levels, upregulating the cytochrome P450-2E1 (CYP2E1) and promoting cell death. The use of antioxidants such as N-acetylcysteine (NAC) and diallyl sulfide (DAS), which is also a CYP2E1 inhibitor, reverted cell death and oxidative stress, modulating also the upstream angiogenesis and inflammation regulators. Because oxidative stress plays a central role in most frequent ocular diseases, the results herein support the proposal that CYP2E1 upregulation could aggravate retinal degeneration, especially in those patients with high baseline oxidative stress levels due to their ocular pathology and should be considered as a risk factor.
Identifiants
pubmed: 32825644
pii: antiox9090776
doi: 10.3390/antiox9090776
pmc: PMC7555214
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Conselleria de Cultura, Educación y Ciencia, Generalitat Valenciana
ID : PROMETEO 94/2016
Références
Oxid Med Cell Longev. 2018 Nov 21;2018:1610751
pubmed: 30584457
J Cell Mol Med. 2016 Aug;20(8):1457-66
pubmed: 26999719
Free Radic Biol Med. 2008 Mar 1;44(5):723-38
pubmed: 18078827
Clin Interv Aging. 2017 Oct 03;12:1579-1587
pubmed: 29042759
Nat Commun. 2019 Jul 26;10(1):3347
pubmed: 31350409
J Ophthalmol. 2015;2015:627674
pubmed: 26417453
Oxid Med Cell Longev. 2017;2017:9208489
pubmed: 28194256
Cell Death Dis. 2018 Jul 9;9(7):753
pubmed: 29988039
J Cell Sci. 2004 Oct 15;117(Pt 22):5197-208
pubmed: 15483317
Mol Pharmacol. 1998 Apr;53(4):638-48
pubmed: 9547353
Cell Death Dis. 2013 Mar 21;4:e554
pubmed: 23519123
Int J Mol Sci. 2019 May 14;20(10):
pubmed: 31091656
Mol Vis. 2013;19:281-91
pubmed: 23401656
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6855-63
pubmed: 26567798
Int Rev Cytol. 2002;215:395-431
pubmed: 11952236
Invest Ophthalmol Vis Sci. 2004 May;45(5):1562-5
pubmed: 15111615
Int Rev Cytol. 2000;196:245-313
pubmed: 10730217
Mol Ther. 2016 May;24(5):890-902
pubmed: 26775809
Cell Death Dis. 2014 Jul 17;5:e1328
pubmed: 25032851
PLoS One. 2015 May 13;10(5):e0124940
pubmed: 25970164
Neuroscience. 2007 Mar 30;145(3):1120-9
pubmed: 17293057
Acta Ophthalmol. 2012 Sep;90(6):571-9
pubmed: 20670344
Front Pharmacol. 2018 Nov 05;9:1280
pubmed: 30455645
Cells. 2019 Nov 04;8(11):
pubmed: 31689891
Oxid Med Cell Longev. 2016;2016:3164734
pubmed: 26881021
Curr Drug Metab. 2009 Feb;10(2):164-78
pubmed: 19275551
Mol Vis. 2016 Feb 03;22:116-28
pubmed: 26900328
Methods Enzymol. 2013;528:27-48
pubmed: 23849857
J Biol Chem. 2013 Aug 16;288(33):23928-42
pubmed: 23818523
Front Immunol. 2019 Jul 16;10:1618
pubmed: 31379825
Prog Retin Eye Res. 2014 Nov;43:17-75
pubmed: 25038518
Curr Res Transl Med. 2019 May;67(2):62-71
pubmed: 30685380
J Biol Chem. 2016 Mar 18;291(12):6494-506
pubmed: 26814131
Antioxidants (Basel). 2020 Jan 06;9(1):
pubmed: 31935797
Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2652-9
pubmed: 10509662
Sci Rep. 2015 Sep 29;5:14362
pubmed: 26415877
Eye (Lond). 2007 Dec;21(12):1511-5
pubmed: 17304258
Mol Med Rep. 2012 Jan;5(1):54-9
pubmed: 21909619
Cell Physiol Biochem. 2018;49(1):359-367
pubmed: 30138927
PLoS One. 2011;6(12):e28947
pubmed: 22174934
Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2377-82
pubmed: 23341606
Cytokine. 2017 Jul;95:126-135
pubmed: 28282610
Front Neurosci. 2019 May 17;13:461
pubmed: 31156364
Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2767-73
pubmed: 12147614
FASEB J. 2006 Feb;20(2):323-5
pubmed: 16368716
Invest Ophthalmol Vis Sci. 2013 Jan 07;54(1):47-56
pubmed: 23221079
J Biol Chem. 2009 Oct 30;284(44):30177-86
pubmed: 19723623
Oxid Med Cell Longev. 2017;2017:4680732
pubmed: 28163821
Clin Sci (Lond). 2015 Jun;128(11):805-23
pubmed: 25881671
Clin Sci (Lond). 2013 May;124(10):597-615
pubmed: 23379642
Cell Cycle. 2019 Feb;18(4):413-424
pubmed: 30739530
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8795-800
pubmed: 9671758
Biomed Res Int. 2014;2014:768026
pubmed: 24707498
Free Radic Biol Med. 2016 Feb;91:188-202
pubmed: 26703967
Exp Eye Res. 2010 Jun;90(6):718-25
pubmed: 20230819
Cardiovasc Res. 2014 Jan 1;101(1):145-54
pubmed: 24130189
Prog Retin Eye Res. 2003 Sep;22(5):683-703
pubmed: 12892646
Invest Ophthalmol Vis Sci. 2012 Apr 18;53(4):1953-61
pubmed: 22408008
World J Gastroenterol. 2016 Dec 7;22(45):9974-9983
pubmed: 28018104
Genes Nutr. 2010 Jun;5(2):149-67
pubmed: 19798529
Eur J Ophthalmol. 2011;21 Suppl 6:S3-9
pubmed: 23264323
Breast Cancer Res. 2013 Nov 08;15(6):R107
pubmed: 24207099
PLoS One. 2012;7(9):e44478
pubmed: 22957075
J Cell Mol Med. 2013 Jul;17(7):833-43
pubmed: 23663427
Free Radic Biol Med. 2010 Jan 15;48(2):216-22
pubmed: 19854264
Invest Ophthalmol Vis Sci. 2003 Dec;44(12):5383-95
pubmed: 14638742
Physiol Rev. 2005 Jul;85(3):845-81
pubmed: 15987797
Am J Ophthalmol. 1999 Jun;127(6):694-709
pubmed: 10372880
PLoS One. 2013 Dec 31;8(12):e85857
pubmed: 24392031